Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

10.21
Delayed Data
As of Mar 27
 -0.09 / -0.87%
Today’s Change
4.07
Today|||52-Week Range
12.88
+8.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues19.1M17.4M31.5M53.8M
 
 
 
 
 
Cost of Goods Sold10.0M8.7M11.7M14.8M
 
 
 
 
 
Depreciation And Amortization2.2M2.0M10.2M18.7M
 
 
 
 
 
 
Operating ExpensesGross Income6.9M6.7M9.6M20.3M
 
 
 
 
 
General Expenses14.6M14.1M15.3M22.9M
 
 
 
 
 
Research And Development968.9K345.6K290.0K2.3M
 
 
 
 
 
Total Operating Expenses26.7M24.8M37.2M56.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.7M-7.4M-5.7M-2.5M
 
 
 
 
 
Extraordinary Charge-6.5M------
 
 
Interest Expense On Debt1.4M2.3M5.3M10.0M
 
 
 
 
 
Other Expenses0.00-368.1K6.0K-82.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.4M-10.0M-11.0M-12.6M
 
 
 
 
 
Income Taxes-5.9M-3.7M-655.0K-4.8M
 
 
 
 
 
Net Income-9.5M-6.2M-11.7M-7.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.3M37.8M38.1M38.3M
 
 
 
 
 
Shares To Calculate EPS Diluted37.3M37.8M38.1M38.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.16-$0.31-$0.20
 
 
 
 
 
EPS Diluted-$0.26-$0.16-$0.31-$0.20
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account